(AXS) AXIS Capital Holdings - Overview
Sector: Financial Services | Industry: Insurance - Specialty | Exchange: NYSE (USA) | Market Cap: 7.420m USD | Total Return: -0.5% in 12m
Specialty Insurance, Reinsurance, Liability, Property, Marine Aviation
Total Rating 52
Safety 81
Buy Signal -0.37
Insurance - Specialty
Industry Rotation: +4.9
Industry Rotation: +4.9
Market Cap:
7.42B
Avg Turnover: 54.7M
Avg Turnover: 54.7M
Risk 3d forecast
Volatility22.2%
VaR 5th Pctl4.01%
VaR vs Median9.90%
Reward TTM
Sharpe Ratio-0.10
Rel. Str. IBD29.1
Rel. Str. Peer Group42
Character TTM
Beta0.252
Beta Downside0.191
Hurst Exponent0.537
Drawdowns 3y
Max DD16.73%
CAGR/Max DD1.58
CAGR/Mean DD6.39
EPS (Earnings per Share)
EPS CAGR: 21.87%
EPS Trend: 90.4%
EPS Trend: 90.4%
Last SUE: 0.05
Qual. Beats: 0
Qual. Beats: 0
Revenue
Rev. CAGR: 6.99%
Rev. Trend: 99.3%
Rev. Trend: 99.3%
Last SUE: -0.61
Qual. Beats: 0
Qual. Beats: 0
Warnings
No concerns identified
Tailwinds
No distinct edge detected
Description: AXS AXIS Capital Holdings
AXIS Capital Holdings Limited (NYSE: AXS) is a Bermuda-based specialty insurer and reinsurer operating through two distinct segments: Insurance and Reinsurance. The Insurance division provides coverage for professional liability, property, marine, aviation, and cyber risks, while the Reinsurance division offers risk-transfer solutions for global insurers across property, casualty, and specialty lines.
As a specialty carrier, AXIS focuses on complex risks that often fall outside the standard admitted market, a sector typically characterized by higher volatility but greater pricing flexibility. The company’s dual-segment model allows it to balance primary underwriting income with the broader cyclical trends of the global reinsurance market. Investors looking to analyze the companys historical underwriting performance and valuation metrics can further their research on ValueRay.
Founded in 2001, the firm maintains a significant presence in major insurance hubs, including the U.S. and the Lloyd’s of London market. This geographic and product diversification helps mitigate exposure to localized catastrophic events and specific industry downturns.
- Catastrophic event frequency impacts underwriting profitability and loss reserve adequacy
- Net investment income fluctuates with global interest rates and credit spreads
- Renewables and specialty insurance expansion drives premium growth in core segments
- Reinsurance market hardening influences pricing power and risk retention strategies
- Cyber and professional liability claims trends affect long-term loss ratio targets
Piotroski VR‑10 (Strict)
6.0
| Net Income: 1.07b TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.00 > 0.02 and ΔFCF/TA -4.84 > 1.0 |
| NWC/Revenue: 203.3% < 20% (prev 317.4%; Δ -114.1% < -1%) |
| CFO/TA 0.00 > 3% & CFO 169.4m > Net Income 1.07b |
| Net Debt (-4.31b) to EBITDA (1.44b): -3.00 < 3 |
| Current Ratio: 2.53 > 1.5 & < 3 |
| Outstanding Shares: last quarter (75.2m) vs 12m ago -8.77% < -2% |
| Gross Margin: 40.54% > 18% (prev 0.29%; Δ 4.02k% > 0.5%) |
| Asset Turnover: 19.20% > 50% (prev 18.18%; Δ 1.03% > 0%) |
| Interest Coverage Ratio: 20.21 > 6 (EBITDA TTM 1.44b / Interest Expense TTM 66.5m) |
Altman Z''
3.80
| A: 0.38 (Total Current Assets 22.25b - Total Current Liabilities 8.81b) / Total Assets 35.62b |
| B: 0.24 (Retained Earnings 8.40b / Total Assets 35.62b) |
| C: 0.04 (EBIT TTM 1.34b / Avg Total Assets 34.43b) |
| D: 0.28 (Book Value of Equity 8.30b / Total Liabilities 29.24b) |
| Altman-Z'' Score: 3.80 = AA |
Beneish M
-3.11
| DSRI: 1.09 (Receivables 13.47b/11.35b, Revenue 6.61b/6.04b) |
| GMI: 0.71 (GM 40.54% / 28.90%) |
| AQI: 1.02 (AQ_t 0.37 / AQ_t-1 0.36) |
| SGI: 1.09 (Revenue 6.61b / 6.04b) |
| TATA: 0.03 (NI 1.07b - CFO 169.4m) / TA 35.62b) |
| Beneish M-Score: -3.11 (Cap -4..+1) = AA |
What is the price of AXS shares?
As of May 21, 2026, the stock is trading at USD 100.55 with a total of 335,456 shares traded.
Over the past week, the price has changed by +3.38%, over one month by -1.21%, over three months by -3.83% and over the past year by -0.51%.
Over the past week, the price has changed by +3.38%, over one month by -1.21%, over three months by -3.83% and over the past year by -0.51%.
Is AXS a buy, sell or hold?
AXIS Capital Holdings has received a consensus analysts rating of 4.11.
Therefore, it is recommended to buy AXS.
- StrongBuy: 4
- Buy: 2
- Hold: 3
- Sell: 0
- StrongSell: 0
What are the forecasts/targets for the AXS price?
| Analysts Target Price | 122.4 | 21.7% |
AXIS Capital Holdings (AXS) - Fundamental Data Overview
as of 20 May 2026
P/E Trailing = 7.5217 P/E Forward = 7.4349
P/S = 1.1098
P/B = 1.2567
P/EG = 1.1787
Revenue TTM = 6.61b USD
EBIT TTM = 1.34b USD
EBITDA TTM = 1.44b USD
Long Term Debt = 1.38b USD (from longTermDebt, last quarter)
Short Term Debt = unknown (none)
Debt = 1.49b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = -4.31b USD (recalculated: Debt 1.49b - CCE 5.80b)
Enterprise Value = 3.11b USD (7.42b + Debt 1.49b - CCE 5.80b)
Interest Coverage Ratio = 20.21 (Ebit TTM 1.34b / Interest Expense TTM 66.5m)
EV/FCF = 18.37x (Enterprise Value 3.11b / FCF TTM 169.4m)
FCF Yield = 5.44% (FCF TTM 169.4m / Enterprise Value 3.11b)
FCF Margin = 2.56% (FCF TTM 169.4m / Revenue TTM 6.61b)
Net Margin = 16.18% (Net Income TTM 1.07b / Revenue TTM 6.61b)
Gross Margin = 40.54% ((Revenue TTM 6.61b - Cost of Revenue TTM 3.93b) / Revenue TTM)
Gross Margin QoQ = 47.23% (prev 50.45%)
Tobins Q-Ratio = 0.09 (Enterprise Value 3.11b / Total Assets 35.62b)
Interest Expense / Debt = 1.10% (Interest Expense 16.4m / Debt 1.49b)
Taxrate = 18.11% (55.8m / 308.1m)
NOPAT = 1.10b (EBIT 1.34b * (1 - 18.11%))
Current Ratio = 2.53 (Total Current Assets 22.25b / Total Current Liabilities 8.81b)
Debt / Equity = 0.23 (Debt 1.49b / totalStockholderEquity, last quarter 6.38b)
Debt / EBITDA = -3.00 (Net Debt -4.31b / EBITDA 1.44b)
Debt / FCF = -25.43 (Net Debt -4.31b / FCF TTM 169.4m)
Total Stockholder Equity = 6.32b (last 4 quarters mean from totalStockholderEquity)
RoA = 3.11% (Net Income 1.07b / Total Assets 35.62b)
RoE = 16.93% (Net Income TTM 1.07b / Total Stockholder Equity 6.32b)
RoCE = 17.45% (EBIT 1.34b / Capital Employed (Equity 6.32b + L.T.Debt 1.38b))
RoIC = 15.39% (NOPAT 1.10b / Invested Capital 7.15b)
WACC = 5.87% (E(7.42b)/V(8.91b) * Re(6.87%) + D(1.49b)/V(8.91b) * Rd(1.10%) * (1-Tc(0.18)))
Discount Rate = 6.87% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 7.92%
Shares (quarterly) Correlation: -85.40 | Cagr: -5.46%
[DCF] Terminal Value 86.36% ; FCFF base≈809.2m ; Y1≈811.2m ; Y5≈864.7m
[DCF] Fair Price = 406.9 (EV 25.69b - Net Debt -4.31b = Equity 30.00b / Shares 73.7m; r=6.0% [WACC]; 5y FCF grow -0.30% → 3.0% )
EPS Correlation: 90.43 | EPS CAGR: 21.87% | SUE: 0.05 | # QB: 0
Revenue Correlation: 99.25 | Revenue CAGR: 6.99% | SUE: -0.61 | # QB: 0
EPS current Quarter (2026-06-30): EPS=3.44 | Chg30d=-0.43% | Revisions=-20% | Analysts=12
EPS next Quarter (2026-09-30): EPS=2.98 | Chg30d=-0.78% | Revisions=-29% | Analysts=12
EPS current Year (2026-12-31): EPS=13.24 | Chg30d=-0.39% | Revisions=-33% | GrowthEPS=+2.5% | GrowthRev=+6.6%
EPS next Year (2027-12-31): EPS=14.51 | Chg30d=-0.11% | Revisions=-23% | GrowthEPS=+9.6% | GrowthRev=+6.1%
[Analyst] Revisions Ratio: -33%